Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 18, 2020
Asklepios has entered into a research collaboration and licensing agreement with the UNC for the development and commercialization of gene therapy for Angelman syndrome.
read more
Monday, December 06, 2021
ASLAN Pharmaceuticals announced the appointment of IQVIA Biotech, a provider of analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred clinical research organization for logistics related to ...
read more
Selexis SA, a life sciences company and a provider of mammalian (suspension-adapted CHO-K1) cell line generation, and ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumor ...
read more
Monday, September 30, 2019
ASLAN and Bukwang announced they have established a new joint venture to develop preclinical aryl hydrocarbon receptor (AhR) antagonists from ASLAN’s early stage pipeline.
read more
ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (referred to as DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing...
read more
Celerion has announced that effective January 1, 2016, Assign Clinical Research, headquartered in Vienna, Austria, has joined Celerion, further expanding their global presence and capabilities in the conduct of complex early clinical studies.
read more
Wednesday, April 22, 2020
Assistek announced the release of its novel web-based eCOA solution to support remote data collection for patients and sites due to the COVID-19 pandemic.
read more
Friday, December 01, 2017
Astellas Pharma and Mitobridge announced Astellas has exercised its exclusive option right to acquire Mitobridge under the amended terms of the October 2013 partnership agreement.
read more
Astellas Pharma Inc. announced that the FDA has placed a clinical hold on the FORTIS Phase 1/2 trial following the occurrence of a serious adverse event (SAE) of peripheral sensory neuropathy in one of the trial participants.
read more
Wednesday, January 24, 2018
Astellas Pharma has completed the acquisition of Mitobridge.
read more
Astellas Pharma Inc. and DigiTx Partners LLC announced that Astellas has launched DigiTx Partners, a digital health investment company in partnership with MPM Capital, Inc. DigiTx Partners will invest in the digital health space broadly, with a ...
read more
AIRM and Universal Cells have entered into an exclusive worldwide license agreement to research, develop and commercialize a novel cell therapy for an undisclosed indication.
read more
Wednesday, August 12, 2015
Asterand Bioscience has announced the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens.
read more
Wednesday, February 15, 2017
Asterand Bioscience has announced a partnership with MolecularMD to combine MolecularMD’s expertise as a provider of molecular diagnostics products and services with Asterand Bio’s drug target and candidate validation capabilities.
read more
Wednesday, February 17, 2016
Asterand Bioscience has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
read more